It is difficult to speculate about the effects of MRA and SGLT2 inhibitors in patients with HF and severe CKD, since MRA can affect kidney function and cause hyperkalemia, and there are few studies on the effect of SGLT2 inhibitors in these patients. Here, SLC5A2 is linked to chronic kidney disease.